Recent Finacing
Recent Raise
Scandion Oncology is a Copenhagen-based biotech developing drugs and predictive biomarkers to overcome chemotherapy resistance, advancing lead candidate SCO-101 toward Phase 2a with GMP manufacturing and an analogue platform.
Focus Areas
Total Raised
Funding round